MPM BioVentures 2018 LLC insider trades: Entrada Therapeutics (TRDA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where MPM BioVentures 2018 LLC reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | TRDA | ↓ Sell | 86,914 | $7.08 | $616K | Indirect | Aug 31, 2026 (0d) |
| Aug 26, 2026 | TRDA | ↓ Sell | 62,714 | $7.36 | $462K | Indirect | Aug 26, 2026 (0d) |
| Jan 12, 2026 | AKTS | ↑ Buy | 1,112,777 | $18.00 | $20.0M | Indirect | Jan 14, 2026 (2d) |
| May 13, 2025 | ITOS | ↓ Sell | 630,191 | $8.06 | $5.1M | Indirect | May 15, 2025 (2d) |
| Dec 11, 2024 | TRDA | ↓ Sell | 44,722 | $20.51 | $917K | Indirect | Dec 12, 2024 (1d) |
| Jan 5, 2022 | ITOS | ↓ Sell | 146,685 | $42.58 | $6.2M | Indirect | Jan 6, 2022 (1d) |
| Dec 7, 2021 | ITOS | ↓ Sell | 49,831 | $33.73 | $1.7M | Indirect | Dec 7, 2021 (0d) |
| Dec 2, 2021 | ITOS | ↓ Sell | 76,089 | $34.43 | $2.6M | Indirect | Dec 2, 2021 (0d) |
| Dec 2, 2021 | ITOS | ↓ Sell | 7,430 | $34.83 | $259K | See Fpotnote | Dec 2, 2021 (0d) |
| Nov 29, 2021 | ITOS | ↓ Sell | 23,045 | $35.18 | $811K | Indirect | Nov 30, 2021 (1d) |
| Nov 24, 2021 | ITOS | ↓ Sell | 77,455 | $36.61 | $2.8M | Indirect | Nov 24, 2021 (0d) |
| Nov 2, 2021 | TRDA | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Nov 4, 2021 (2d) |
| Oct 18, 2021 | ITOS | ↓ Sell | 17,099 | $27.45 | $469K | Indirect | Oct 18, 2021 (0d) |
| Oct 14, 2021 | ITOS | ↓ Sell | 56,770 | $27.21 | $1.5M | Indirect | Oct 14, 2021 (0d) |
| Oct 11, 2021 | ITOS | ↓ Sell | 51,993 | $27.23 | $1.4M | Indirect | Oct 12, 2021 (1d) |
| Oct 4, 2021 | ITOS | ↓ Sell | 27,566 | $27.05 | $746K | Indirect | Oct 5, 2021 (1d) |
| Sep 30, 2021 | ITOS | ↓ Sell | 21,506 | $27.00 | $581K | Indirect | Sep 30, 2021 (0d) |
| Sep 27, 2021 | ITOS | ↓ Sell | 53,468 | $27.76 | $1.5M | Indirect | Sep 27, 2021 (0d) |
| Sep 22, 2021 | ITOS | ↓ Sell | 33,929 | $27.50 | $933K | Indirect | Sep 23, 2021 (1d) |
| Sep 20, 2021 | ITOS | ↓ Sell | 91,254 | $28.38 | $2.6M | Indirect | Sep 20, 2021 (0d) |
| Sep 15, 2021 | ITOS | ↓ Sell | 45,665 | $27.70 | $1.3M | Indirect | Sep 16, 2021 (1d) |
| Sep 13, 2021 | ITOS | ↓ Sell | 57,640 | $28.32 | $1.6M | Indirect | Sep 13, 2021 (0d) |
| Sep 8, 2021 | ITOS | ↓ Sell | 42,566 | $29.03 | $1.2M | Indirect | Sep 8, 2021 (0d) |
| Apr 9, 2021 | ITOS | ↓ Sell | 119 | $29.99 | $4K | Indirect | Apr 13, 2021 (4d) |
| Apr 8, 2021 | ITOS | ↓ Sell | 25,087 | $30.99 | $777K | Indirect | Apr 9, 2021 (1d) |
| Jul 28, 2020 | ITOS | ↑ Buy | 160,000 | $19.00 | $3.0M | Indirect | Jul 29, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TRDA insiders
Open-market trades in the last 12 months
About MPM BioVentures 2018 LLC's insider trades
MPM BioVentures 2018 LLC is a 10% owner of Entrada Therapeutics (TRDA). Since Jul 28, 2020, it has reported 3 open-market purchases worth $25.1M and 23 sales worth $36.2M on SEC Form 4. In the last 12 months: 1 buy ($20.0M) and 2 sales ($1.1M).
Its filings also include conversions (4 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.